Protecting the blood supply against infectious disease by strengthening the evidence base that guides donor selection and screening policy

通过加强指导捐献者选择和筛查政策的证据基础，保护血液供应免受传染病侵害

• 批准号: nhmrc : GNT1151959
• 负责人: A/Pr Barbara Masser
• 金额: $ 73.05万
• 依托单位国家: 澳大利亚
• 项目类别: Partnerships
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/protecting-blood-supply-screening-policy/1349016
• 关键词: Protecting; blood; supply; against; infectious

Donor deferral & screening strategies have been highly effective in reducing the risk of acquiring infections from blood/blood products in Australia. Yet every decision about deferral/screening has a range of costs, so must be weighed carefully using the best available evidence on risk & benefit. We propose to work with the Australian Red Cross Blood Service to strengthen its processes for risk/benefit evaluation to support the overall framework for decision making on donor screening/eligibility

在澳大利亚，献血者延迟和筛查战略在降低从血液/血液制品获得感染的风险方面非常有效。然而，每一个关于延期/筛查的决定都有一系列的成本，因此必须仔细权衡，使用现有的最佳风险和收益证据。我们建议与澳大利亚红十字会血液服务中心合作，加强其风险/效益评估流程，以支持献血者筛选/资格决策的总体框架